Loncarevic, Isidora
Mutlu, Seyran
Dzepic, Martina
Keshavan, Sandeep
Balog, Sandor
Petri-Fink, Alke
Blank, Fabian
Rothen-Rutishauser, Barbara
Funding for this research was provided by:
Swiss National Science Foundation NRP 79 program (Nr. 407940_206331 / 1)
Swiss National Science Foundation NRP 79 program (Nr. 407940_206331 / 1)
Swiss National Science Foundation NRP 79 program (Nr. 407940_206331 / 1)
Swiss National Science Foundation NRP 79 program (Nr. 407940_206331 / 1)
Swiss National Science Foundation NRP 79 program (Nr. 407940_206331 / 1)
Swiss National Science Foundation NRP 79 program (Nr. 407940_206331 / 1)
Adolphe Merkle Foundation
Article History
Received: 27 February 2025
Accepted: 2 February 2026
First Online: 19 February 2026
Declarations
:
: Experiments involving primary monocyte isolation from human blood were approved by the committee of the Federal Office for Public Health Switzerland (reference number: 611-1, Meldung A110635/2) for the Adolphe Merkle Institute. Animal experiments were approved by The Swiss Federal Veterinary Office of the Cantonal Ethical Committee for Animal Experiments (Amt für Landwirtschaft und Natur des Kantons Bern) under permission number BE 90/2022. All rats received humane care in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Research. All experiments were performed following the European Convention of Animal Care standards.
: Not applicable.
: The authors declare no competing interests.